Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09ELC
|
|||
| Former ID |
DIB006345
|
|||
| Drug Name |
AVI-7537
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Ebola virus infection [ICD-11: 1D60.0] | Phase 1 | [1] | |
| Company |
Sarepta therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ebola virus VP24 messenger RNA (EV VP24 mRNA) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01593072) A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers. U.S. National Institutes of Health. | |||
| REF 2 | Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections. Viruses. 2012 November; 4(11): 2806-2830. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.